Skip to main navigation Skip to search Skip to main content

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

  • Paulus Kirchhof
  • , Dietrich Andresen
  • , Ralph Bosch
  • , Martin Borggrefe
  • , Thomas Meinertz
  • , Ulli Parade
  • , Ursula Ravens
  • , Alexander Samol
  • , Gerhard Steinbeck
  • , Andras Treszl
  • , Karl Wegscheider
  • , Günter Breithardt

Research output: Contribution to journalArticlepeer-review

91 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science